Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Neurogastroenterol Motil. 2013 Feb 17;25(5):427–e301. doi: 10.1111/nmo.12091

Table 1.

RELATION OF UPPER ABDOMINAL PAIN/UPPER ABDOMINAL DISCOMFORT TO BASELINE CHARACTERISTICS OF GASTROPARESIS PATIENTS

Characteristic Upper Abdominal
Pain/Upper
Abdominal
Discomfort Score ≥3
N=288
Upper Abdominal
Pain/Upper
Abdominal
Discomfort Score <3
N=105
Difference
(95% CI)*
P
Demographic and clinical factors Age at enrollment (years) 42.1±13.5 43.6±14.7 −1.5 (−4.6, 1.6) 0.35
Female sex 246 (85%) 81 (77%) 8% (−1%, 18%) 0.052
Hispanic ethnicity 14 (5%) 5 (5%) 0% (−6%, 5%) 1.00
Race:
White
Black
Other
 
249 (87%)
27 (9%)
9 (3%)
 
88 (85%)
11 (11%)
4 (4%)
 
2% (−7%, 10%)
−2% (−9%, 6%)
−1% (−6%, 4%)
0.82
Gastroparesis etiology:
Diabetic
Idiopathic
 
92 (32%)
196 (68%)
 
45 (43%)
60 (57%)
 
−11% (−22%, 1%)
11% (−1%, 22%)
0.045
Acute symptom onset 145 (51%) 58 (56%) −5% (−17%, 7%) 0.36
Initial infectious prodrome 44 (15%) 23 (22%) −7% (−16%, 3%) 0.122
Gastroparesis severity measures Clinician-rated severity:
Grade 1
Grade 2
Grade 3
 
27 (9%)
156 (55%)
103 (36%)
 
22 (21%)
52 (50%)
30 (29%)
 
−12% (−21%, −3%)
5% (−7%, 16%)
7% (−4%, 18%)
0.008
GCSI:
Overall
Nausea/vomiting subscale
Postprandial fullness/early satiety subscale
Bloating subscale
 
3.3±0.9
2.8±1.3
3.7±0.9
3.3±1.5
 
2.2±1.0
1.9±1.5
2.5±1.1
2.0±1.5
 
1.1 (0.9, 1.3)
0.9 (0.5, 1.2)
1.2 (1.0, 1.4)
1.3 (1.0, 1.6)
 
<0.001
<0.001
<0.001
<0.001
PAGI-SYM:
Lower abdominal pain
Lower abdominal discomfort
Constipation
Diarrhea
 
2.5±1.6
2.6±1.6
2.8±1.7
2.1±1.7
 
1.2±1.4
1.4±1.5
1.5±1.6
1.4±1.5
 
1.3 (1.0, 1.7)
1.2 (0.8, 1.5)
1.2 (0.8, 1.6)
0.6 (0.2, 1.0)
 
<0.001
<0.001
<0.001
0.001
Quality of life measures PAGI-QOL 2.1±1.0 3.2±0.9 −1.1 (−1.3, −0.9) <0.001
SF-36:
Physical component
Mental component
 
31.0±9.1
34.8±12.1
 
38.5±10.7
42.3±12.3
 
−7.5 (−9.7, −5.4)
−7.4 (−10.2, −4.7)
 
<0.001
<0.001
BPI:
Overall pain interference score
General activity
Mood
Walking ability
Normal work
Relations with people
Sleep
Enjoyment of life
 
5.9±2.5
6.0±3.0
6.3±2.9
4.7±3.2
6.3±3.1
5.1±3.2
6.2±3.1
6.5±3.1
 
3.7±2.7
3.6±3.2
3.9±3.1
3.0±3.2
4.4±3.4
3.2±3.1
3.6±3.4
4.2±3.3
 
2.2 (1.5, 2.9)
2.3 (1.5, 3.2)
2.4 (1.6, 3.2)
1.7 (0.8, 2.6)
1.9 (1.0, 2.8)
1.8 (0.9, 2.7)
2.6 (1.7, 3.5)
2.3 (1.4, 3.2)
 
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
Parameters of psychological dysfunction BDI 21.2±11.3 14.3±9.3 6.9 (4.5, 9.3) <0.001
STAI:
Y1 state anxiety
Y2 trait anxiety
 
47.9±13.4
46.4±12.3
 
39.6±11.8
39.7±11.5
 
8.3 (5.3, 11.2)
6.7 (4.0, 9.4)
 
<0.001
<0.001
Gastric emptying Gastric retention (%):
2 hour
4 hour
 
64.3±18.2
32.7±22.3
 
64.4±19.1
32.7±23.5
 
−0.1 (−4.2, 4.1)
0.1 (−5.0, 5.1)
 
0.97
0.98
Medication use Prokinetics
Antiemetics
Opiates
Neuropathic pain modulators
Antidepressants
157 (54%)
191 (66%)
138 (48%)
59 (20%)
109 (38%)
61 (58%)
58 (55%)
35 (33%)
19 (18%)
34 (32%)
−4% (−15%, 8%)
11% (−1%, 23%)
15% (3%, 26%)
2% (−7%, 12%)
6% (−6%, 17%)
0.53
0.044
0.009
0.60
0.32

All data are mean±SD or N (%)

*

Differences in means (95% CI) are presented for continuous variables and differences in proportions (95% CI) are presented for categorical variables. The 95% CIs for differences in means were based on the t-distribution; intervals for differences in proportions used the Newcombe score method with continuity correction.

GCSI: Gastroparesis Cardinal Symptom Index

PAGI-SYM: Patient Assessment of Upper Gastrointestinal Disorders Symptoms

PAGI-QOL: Patient Assessment of Upper Gastrointestinal Disorders Quality of Life

SF-36: Short Form-36

BPI: Brief Pain Inventory

BDI: Beck Depression Inventory

STAI: State and Trait Anxiety Inventory